We are live on
!
Find out more
ACJ
Autonomy Capital (Jersey) Portfolio holdings
AUM
$54.8M
1-Year Est. Return
37.27%
This Fund
S&P 500
This Quarter
Est. Return
-8.98%
1 Year Est. Return
+37.27%
3 Year Est. Return
+33.45%
5 Year Est. Return
-12.01%
10 Year Est. Return
-33.76%
AUM
$1.02B
AUM Growth
+$385M
(+61%)
Cap. Flow
+$347M
Cap. Flow
% of AUM
34.14%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
–
Increased
1
Reduced
3
Closed
8
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AES
AES
|
+$32.3M |
| 2 |
Illumina
ILMN
|
+$17.5M |
| 3 |
iShares Global Clean Energy ETF
ICLN
|
+$16.3M |
| 4 |
ASML
ASML
|
+$13.6M |
| 5 |
Beyond Meat
BYND
|
+$4.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 1.29% |
| 2 | Healthcare | 0.18% |
| 3 | Consumer Staples | 0.1% |
| 4 | Technology | 0% |
| 5 | Utilities | 0% |
Similar funds
UFG
KC
SC
LR
JCI
AP
RTM
AOGP
Autonomy Capital (Jersey)'s Q1 2021 Portfolio in Review
As of Q1 2021, Autonomy Capital (Jersey) held 13 positions worth $1.02B, up 61% from $632M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Autonomy Capital (Jersey) deployed $347M of net new capital in Q1 2021, adding to 1 existing holding.
By sector, the portfolio is most concentrated in Real Estate at 1.3% of assets, down from 2.3% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Genmab, an estimated $45K trimmed.
- Autonomy Capital (Jersey)'s biggest Q1 2021 reduction was Genmab, cutting an estimated $45K.
- Autonomy Capital (Jersey) fully exited AES in Q1 2021, selling an estimated $32.3M.
- Autonomy Capital (Jersey)'s ten largest holdings make up 100% of its $1.02B portfolio in Q1 2021.
- Autonomy Capital (Jersey) opened 0 new positions and closed 8 in Q1 2021.
- Autonomy Capital (Jersey)'s portfolio value rose 61% quarter-over-quarter to $1.02B.
Based on Autonomy Capital (Jersey)'s 13F filing for Q1 2021, filed 17 May 2021.